Venezuela IEC 60601 Compliance 2026: Electrical Safety, EMC and Grid Adaptation

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Active medical devices submitted in Venezuela must be supported by electrical safety and electromagnetic compatibility (EMC) evidence, normally based on the IEC 60601 series. The critical point is that the evidence must cover local grid conditions in Venezuela, including voltage and frequency.

GRZAN’s assessment: an IEC 60601 test report issued in the country of origin is usually acceptable at the level of the standard, but where its test conditions do not cover Venezuelan grid parameters, additional verification in a Venezuelan accredited laboratory may still be required. This is the most underestimated source of time and cost in active device projects, because it appears after the technical file is otherwise complete and it adds a dependency that cannot be planned around at short notice.

The exposure is asymmetric. A passive device project can ignore this question entirely; an active device project that ignores it may discover, months into the review, that the only remaining item is a test that has not been scheduled. Screening for the issue at the start of the project costs a single question to the authorized representative, and the answer determines whether the test report is enough or whether a local testing slot must be requested.

2. Legal basis

Regulation or documentReference numberPublication dateProvision or key point
IEC 60601 seriesIEC 60601Current versionSafety and essential performance standards for medical electrical equipment
Ley Orgánica de Salud (Health Organization Law)Gaceta Oficial N° 36.579November 11, 1998Legal basis for the regulation of health products
Circular N° DGSACS/0002/2025DGSACS/0002/2025October 28, 2025Procedure handled through the COMEX platform
Local testing requirementIndustry material—INHRR or its accredited laboratories may require additional verification (practical estimate)

Scope statement: the statements that IEC 60601 evidence must be provided and that additional testing in a Venezuelan accredited laboratory may be required derive from industry material and are marked as a practical estimate. IEC 60601 is an international standard, not a Venezuelan national regulation.

3. Expert insights

Insight one: grid adaptation carries particular weight in Venezuela.

Venezuela’s power supply infrastructure experiences voltage fluctuation and unstable supply. For precision equipment that depends on stable power, such as imaging equipment, in vitro diagnostic analysers and life support devices, operating stability under actual conditions is a substantive patient safety question rather than a technical parameter. A device that performs to specification in a laboratory and resets during a brownout has a safety profile that the test report does not describe.

The clinical context sharpens the point. Equipment used in an intensive care unit or an imaging suite is rarely the only load on the circuit, and the moment of a voltage dip is often the moment when a clinical decision is being supported by that equipment. Assessing the product against realistic supply behaviour, rather than against an idealised laboratory supply, is therefore part of demonstrating safety in the Venezuelan market and belongs in the technical file rather than in the commercial literature.

Insight two: this requirement is directly linked to the local testing function of INHRR.

Where SACS considers that a foreign test report does not cover local operating conditions, it may require additional testing or verification in a Venezuelan accredited laboratory. That testing is performed by INHRR or its accredited laboratories, and scheduling is subject to competition from public health tasks, as discussed in the fifth article of this series. Whether local testing is required should therefore be confirmed as early as possible, because the constraint is not only the test itself but the queue in front of it.

Insight three: EMC has to be read against the local electromagnetic environment, not only the grid.

Beyond supply conditions, the electromagnetic environment of the place of use, for example coexistence with other equipment in a hospital, can become a review concern. For high-risk equipment, providing installation requirements and warnings about the operating environment can partially substitute for local measurement. The judgement is whether the intended environment has been described precisely enough that the reviewer can see how interference risks are controlled in practice.

Two practical inputs make that description credible. The first is a site profile, describing the kind of facility in which the device is expected to operate and the equipment it will coexist with. The second is a set of installation and separation requirements that the user can follow without technical training. Together they convert a general statement about electromagnetic compatibility into an operating instruction, which is what a reviewer can actually assess.

Insight four: adaptation evidence can take several forms and does not have to rely entirely on measurement.

Technical specifications showing a wide input range, for example 100 to 240 V at 50 or 60 Hz, a manufacturer’s declaration of suitability, and a history of use under comparable grid conditions can all serve as supporting evidence. The question is whether the combination of evidence is sufficient, not whether a local report exists. A file that explains the design margin and supports it with field experience is often more persuasive than a single test performed under conditions the reviewer cannot verify.

Field history deserves specific treatment. Installed base records, service logs showing no supply-related failures, and written statements from distributors in comparable markets can be assembled into a short annex. The annex should state what the records show and what they do not show, because an overclaiming declaration invites doubt about the rest of the evidence, while a precisely bounded one supports the conclusion the sponsor needs.

4. Practical recommendations

  1. State the voltage and frequency range of the product explicitly in the technical file, and prefer a wide-range design where the product allows it.
  2. Confirm through the authorized representative, in advance, whether this product triggers a local testing requirement, and if it does, request a testing slot immediately.
  3. Provide a manufacturer’s declaration of suitability for the local grid, supported by the technical specifications and by records of use under comparable conditions.
  4. For power-sensitive precision equipment, state installation environment requirements in the instructions for use, such as a recommendation for voltage stabilization or an uninterruptible power supply, as a risk mitigation measure.

5. Verification checklist

  • □ The voltage and frequency range is stated in the technical file
  • □ It has been confirmed whether this product triggers local electrical safety or EMC testing in Venezuela
  • □ A manufacturer’s declaration of suitability has been issued and is supported by technical specifications
  • □ Installation environment requirements for precision equipment are stated in the instructions for use
  • □ Test report validity covers the expected review period

Regulatory information verified as of October 29, 2026.

For a product-specific feasibility assessment of Venezuela market entry, GRZAN’s regulatory team supports manufacturers, importers and authorized representatives with registration dossiers, conformity documentation and submissions to the Venezuelan health authority. Contact info@grzanglobal.com to discuss your project.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail